Serial direct sodium removal in patients with heart failure and diuretic resistance

被引:3
|
作者
Rao, Veena S. [1 ,11 ]
Ivey-Miranda, Juan B. [1 ,2 ]
Cox, Zachary L. [3 ,4 ]
Moreno-Villagomez, Julieta [1 ,5 ]
Ramos-Mastache, Daniela [5 ]
Neville, Daniel [1 ]
Balkcom, Natasha [1 ]
Asher, Jennifer L. [6 ]
Bellumkonda, Lavanya [1 ]
Bigvava, Tamar [7 ]
Shaburishvili, Tamaz [7 ]
Bartunek, Jozef [8 ]
Wilson, F. Perry [9 ,10 ]
Finkelstein, Fredrick [9 ]
Maulion, Christopher [1 ]
Turner, Jeffrey M. [9 ]
Testani, Jeffrey M. [1 ,11 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
[2] Inst Mexicano Seguro Social, Hosp Cardiol, Mexico City, Mexico
[3] Lipscomb Univ, Dept Pharm Practice, Coll Pharm, Nashville, TN USA
[4] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA
[5] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Mexico City, Mexico
[6] Yale Univ, Sch Med, Dept Med, Div Comparat Med, New Haven, CT USA
[7] Tbilisi Heart & Vasc Clin, 18-20 Ljubljana St, Tbilisi 0159, Georgia
[8] Onze Lieve Vrouw Hosp, Cardiovasc Ctr, Aalst, Belgium
[9] Yale Univ, Sch Med, Dept Med, Div Nephrol, New Haven, CT USA
[10] Yale Univ, Sch Med, Clin & Translat Res Accelerator, New Haven, CT USA
[11] Yale Univ, 135 Coll St,Suite 230, New Haven, CT 06510 USA
关键词
Cardiorenal syndrome; Diuretic; Heart failure; Sodium; SALT INTAKE; PATHOPHYSIOLOGY; ULTRAFILTRATION; STRATEGIES; INSIGHTS; THERAPY; BALANCE; STORAGE; KIDNEY;
D O I
10.1002/ejhf.3196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Loop diuretics may exacerbate cardiorenal syndrome (CRS) in heart failure (HF). Direct sodium removal (DSR) using the peritoneal membrane, in conjunction with complete diuretic withdrawal, may improve CRS and diuretic resistance. Methods and results Patients with HF requiring high-dose loop diuretics were enrolled in two prospective, single-arm studies: RED DESERT (n = 8 euvolaemic patients), and SAHARA (n = 10 hypervolaemic patients). Loop diuretics were withdrawn, and serial DSR was utilized to achieve and maintain euvolaemia. At baseline, participants required a median 240 mg (interquartile range [IQR] 200-400) oral furosemide equivalents/day, which was withdrawn in all participants during DSR (median time of DSR 4 weeks [IQR 4-6]). Diuretic response (queried by formal 40 mg intravenous furosemide challenge and 6 h urine sodium quantification) increased substantially from baseline (81 +/- 37 mmol) to end of DSR (223 +/- 71 mmol, p < 0.001). Median time to re-initiate diuretics was 87 days, and the median re-initiation dose was 8% (IQR 6-10%) of baseline. At 1 year, diuretic dose remained substantially below baseline (30 [IQR 7.5-40] mg furosemide equivalents/day). Multiple dimensions of kidney function such as filtration, uraemic toxin excretion, kidney injury, and electrolyte handling improved (p < 0.05 for all). HF-related biomarkers including N-terminal pro-B-type natriuretic peptide, carbohydrate antigen-125, soluble ST2, interleukin-6, and growth differentiation factor-15 (p < 0.003 for all) also improved. Conclusions In patients with HF and diuretic resistance, serial DSR therapy with loop diuretic withdrawal was feasible and associated with substantial and persistent improvement in diuretic resistance and several cardiorenal parameters. If replicated in randomized controlled studies, DSR may represent a novel therapy for diuretic resistance and CRS. Clinical Trial Registration: RED DESERT (NCT04116034), SAHARA (NCT04882358). [GRAPHICS] .
引用
收藏
页码:1215 / 1230
页数:16
相关论文
共 50 条
  • [21] Diuretic resistance and the role of albumin in congestive heart failure
    Hazim, Carol Fernandez
    Duarte, Gustavo
    Urena, Ana P.
    Jain, Swati
    Mishra, Rishabh
    Vittorio, Timothy J.
    Rodriguez-Guerra, Miguel
    DRUGS IN CONTEXT, 2023, 12
  • [22] Loop diuretic resistance complicating acute heart failure
    Zachary L. Cox
    Jeffrey M. Testani
    Heart Failure Reviews, 2020, 25 : 133 - 145
  • [23] Loop diuretic resistance complicating acute heart failure
    Cox, Zachary L.
    Testani, Jeffrey M.
    HEART FAILURE REVIEWS, 2020, 25 (01) : 133 - 145
  • [24] Renal Mechanisms of Diuretic Resistance in Congestive Heart Failure
    Lameire, Norbert
    KIDNEY AND DIALYSIS, 2023, 3 (01): : 56 - 72
  • [25] Co-Administration of Albumin and Furosemide in Acute Heart Failure with Diuretic Resistance
    Fernandes, Jorge
    Costa, Rita
    Guerreiro, Renato
    Bonifacio, Dulce
    Rodrigues, Ana
    Henriques, Celia
    Branco, Patricia
    Araujo, Ines
    Fonseca, Candida
    ACTA MEDICA PORTUGUESA, 2023, 36 (03) : 193 - 201
  • [26] Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure
    Rao, Veena S.
    Ivey-Miranda, Juan B.
    Cox, Zachary L.
    Riello, Ralph
    Griffin, Matthew
    Fleming, James
    Soucier, Richard
    Sangkachand, Prasama
    O'Brien, Margaret
    LoRusso, Francine
    D'Ambrosi, Julie
    Churchwell, Keith
    Mahoney, Devin
    Bellumkonda, Lavanya
    Asher, Jennifer L.
    Maulion, Christopher
    Turner, Jeffrey M.
    Wilson, F. Perry
    Collins, Sean P.
    Testani, Jeffrey M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (06) : 695 - 708
  • [27] Diuretic therapy and resistance in congestive heart failure
    Ellison, DH
    CARDIOLOGY, 2001, 96 (3-4) : 132 - 143
  • [28] Loop Diuretic Efficiency A Metric of Diuretic Responsiveness With Prognostic Importance in Acute Decompensated Heart Failure
    Testani, Jeffrey M.
    Brisco, Meredith A.
    Turner, Jeffrey M.
    Spatz, Erica S.
    Bellumkonda, Lavanya
    Parikh, Chirag R.
    Tang, W. H. Wilson
    CIRCULATION-HEART FAILURE, 2014, 7 (02) : 261 - 270
  • [29] Prevalence and outcome of diuretic resistance in heart failure
    Joan-Carles Trullàs
    Jesús Casado
    Jose-Luís Morales-Rull
    Francesc Formiga
    Alicia Conde-Martel
    Raúl Quirós
    Francisco Epelde
    Álvaro González-Franco
    Luis Manzano
    Manuel Montero-Pérez-Barquero
    Internal and Emergency Medicine, 2019, 14 : 529 - 537
  • [30] Management of congestion and diuretic resistance in heart failure
    Regolisti, Giuseppe
    Antoniotti, Riccardo
    Pastorini, Guido
    Fani, Filippo
    Fiaccadori, Enrico
    NEPHROLOGY @ POINT OF CARE, 2016, 2 (01): : E73 - E87